Efficacy and Safety of Oral Semaglutide Versus Empagliflozin in Subjects With Type 2 Diabetes Mellitus

NCT02863328 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

822

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetes
Diabetes Mellitus, Type 2

Interventions

DRUG: semaglutide
DRUG: empagliflozin

Sponsor

Novo Nordisk A/S